Affimed N.V. Operating Cycle 2011-2026 | AFMD

Annual Operating Cycle Affimed N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	95.1	105	289	200	136	184	-	-	-

All numbers in EUR currency

Maximum	Minimum	Average
289	95.1	168

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	127	-	-	$ 546 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	237	$ 21.36	4.86 %	$ 998 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Clearside Biomedical CLSD	61.7	-	-	$ 25.3 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Akebia Therapeutics AKBA	210	$ 1.47	5.0 %	$ 378 M	USA
Aquestive Therapeutics AQST	223	$ 4.19	2.7 %	$ 448 M	USA
Arcutis Biotherapeutics ARQT	291	$ 24.12	-0.37 %	$ 3.07 B	USA
Chimerix CMRX	588	-	-	$ 756 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	321	$ 32.59	1.09 %	$ 2.16 B	USA
Autolus Therapeutics plc AUTL	129	$ 1.47	-1.34 %	$ 391 M	Britain
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
CTI BioPharma Corp. CTIC	90.1	-	-	$ 1.2 B	USA